Market closedNon-fractional
enVVeno Medical/NVNO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About enVVeno Medical
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Ticker
NVNO
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Irvine, United States
Employees
31
Website
www.envveno.com
enVVeno Medical Metrics
BasicAdvanced
$73M
Market cap
-
P/E ratio
-$1.66
EPS
1.06
Beta
-
Dividend rate
Price and volume
Market cap
$73M
Beta
1.06
Financial strength
Current ratio
29.084
Quick ratio
28.878
Long term debt to equity
2.296
Total debt to equity
3.108
Management effectiveness
Return on assets (TTM)
-36.75%
Return on equity (TTM)
-57.82%
Valuation
Price to book
1.77
Price to tangible book (TTM)
1.77
Price to free cash flow (TTM)
-4.229
Growth
Earnings per share change (TTM)
-38.93%
3-year earnings per share growth (CAGR)
-28.12%
What the Analysts think about enVVeno Medical
Analyst Ratings
Majority rating from 1 analysts.
enVVeno Medical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$4.9M
-12.50%
Profit margin
0.00%
NaN%
enVVeno Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.58
-$0.45
-$0.36
-$0.31
-
Expected
-$0.49
-$0.48
-$0.46
-$0.40
-$0.36
Surprise
18.37%
-6.25%
-21.74%
-22.50%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for enVVeno Medical stock?
enVVeno Medical (NVNO) has a market cap of $73M as of July 27, 2024.
What is the P/E ratio for enVVeno Medical stock?
The price to earnings (P/E) ratio for enVVeno Medical (NVNO) stock is 0 as of July 27, 2024.
Does enVVeno Medical stock pay dividends?
No, enVVeno Medical (NVNO) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next enVVeno Medical dividend payment date?
enVVeno Medical (NVNO) stock does not pay dividends to its shareholders.
What is the beta indicator for enVVeno Medical?
enVVeno Medical (NVNO) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell enVVeno Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.